Clinical trial
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
NCT00006168 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006168 |
|---|---|
| Title | Ursodiol-Methotrexate for Primary Biliary Cirrhosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis, Biliary |
| Intervention type | Drug |
| Interventions | Methotrexate |
| Start date | Jan 1, 1994 |
| Completion | Mar 1, 2004 |
| First posted | Aug 9, 2000 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: